trial

Is Cognitive Training Neuroprotective in Early Psychosis?

NCTId NCT03049800
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 36 (actual)
Sponsored by University of Minnesota
Primary completion 2021-02-15
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
36 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2017-06-12
Primary completion
2021-02-15
Eligibility
ALL · 16 Years · 35 Years

Interventions & indications

Drugs
Magnetic Resonance Imaging

Sponsors

University of MinnesotaLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Sophia Vinogradov, MDPrincipal Investigator

Sites

1 total
Minneapolis, United States

Facts & assertions

4 sourced
Enrollment
36
Phase
NA
Primary Completion Date
2021-02-15
Status
COMPLETED
relationships
The graph out of here
drug
Magnetic Resonance Imaging
drug
lead_sponsor
University of Minnesota
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Healthy
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Sophia Vinogradov, MD
person